Acentra Health invited US Consul General in Chennai Judith Ravin recently to inaugurate the US based company’s new brand and its continued investment in its growing India-based technology development workforce.
Formed by the 2022 merger of CNSI, a leading provider of innovative healthcare technology solutions with offices in Chennai, and Kepro, a leading provider of technology-enabled care management, quality oversight, and clinical assessment services, Acentra Health’s global workforce serves as a vital partner for healthcare solutions to federal and state government agencies and the commercial sector.
“We are grateful to US Consul General in Chennai Judith Ravin for joining us to recognize Acentra Health’s brand and the critical work our India-based teams are doing to rapidly develop and implement solutions that elevate the healthcare experience for millions of Americans,” said Harish Nanda, executive vice president and chief technology officer, Acentra Health.
He further added, “Ravin is a tireless advocate for strong US-India relations, and we are thankful for her ongoing partnership with the business community.”
With more than six decades of experience in public sector healthcare, Acentra Health’s power lies in the marriage of its capabilities developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings with high-quality care management, quality oversight, and clinical assessment capabilities. By leveraging rich data sets – provider, health plan beneficiary and member, claims and encounter, and social determinants of health, Acentra Health transforms insights into action by bridging the gaps that exist between technology suppliers, policy advisors, and clinicians.
“Acentra Health’s India workforce plays a significant role in enabling the company’s mission, creating products and solutions that help accelerate better health outcomes for Americans who rely on public sector healthcare,” said Gaurav Maini, senior vice president and managing director, Acentra Health India.
“We are proud to support our growing 500+ workforce in carrying out this important work with ongoing investments in their professional development, to include training, career advancement opportunities, and hybrid work arrangements that support work-life balance
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!